Haemophilus B Conjugate (Prp-T) Vaccine / Meningococcal Conjugate Vaccine Dosage

Usual Pediatric Dose for Haemophilus influenzae Prophylaxis

Three dose primary series, ages 2 to 12 months:
Three 0.5 mL doses intramuscularly with at least 1 month between doses

Two dose primary series, ages 3 to 12 months:
Two 0.5 mL doses intramuscularly with at least 2 months between doses

Primary series in preterm infants born between 25 and 36 weeks gestational age, administered between 2 and 12 months of age:
Three 0.5 mL doses intramuscularly with at least 2 months between doses

Booster dose, given between 1 and 2 years of age:
One 0.5 mL dose, at least 6 months after the 3 dose primary vaccination series (or 5 months after the 2 dose primary series).

Comments:

• Use in accordance with official recommendations.
• There are no data on using this vaccine for 1 or 2 doses of the primary vaccination series after other Haemophilus b or meningococcal vaccines.
• It is recommended if the first dose of primary vaccination is done with this vaccine then the entire series should be completed with this vaccine.

Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis

Three dose primary series, ages 2 to 12 months:
Three 0.5 mL doses intramuscularly with at least 1 month between doses

Two dose primary series, ages 3 to 12 months:
Two 0.5 mL doses intramuscularly with at least 2 months between doses

Primary series in preterm infants born between 25 and 36 weeks gestational age, administered between 2 and 12 months of age:
Three 0.5 mL doses intramuscularly with at least 2 months between doses

Booster dose, given between 1 and 2 years of age:
One 0.5 mL dose, at least 6 months after the 3 dose primary vaccination series (or 5 months after the 2 dose primary series).

Comments:

• Use in accordance with official recommendations.
• There are no data on using this vaccine for 1 or 2 doses of the primary vaccination series after other Haemophilus b or meningococcal vaccines.
• It is recommended if the first dose of primary vaccination is done with this vaccine then the entire series should be completed with this vaccine.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

• Hypersensitivity to any of the ingredients
• Hypersensitivity after previous administration of this vaccine
• Acute severe febrile illness; minor infection is not a contraindication

Safety and efficacy have not been established in patients older than 2 years.

Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme: www.mhra.gov.uk/yellowcard

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• For intramuscular use only.
• Under no circumstances should this be given intravenously, intradermally, or subcutaneously.
• The anterolateral thigh is the preferred administration site.
• Children 12 to 24 months may be vaccinated in the deltoid region.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer